Leerink Partners Issues Positive Forecast for Tenet Healthcare (NYSE:THC) Stock Price

Tenet Healthcare (NYSE:THC) had its price objective upped by Leerink Partners from $255.00 to $264.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Wells Fargo & Company reissued an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a research report on Monday. Guggenheim increased their price target on Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research report on Friday, February 13th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Jefferies Financial Group increased their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, UBS Group boosted their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Stock Up 0.6%

Shares of THC stock opened at $229.56 on Friday. The company has a market capitalization of $19.96 billion, a price-to-earnings ratio of 14.82, a P/E/G ratio of 1.12 and a beta of 1.44. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $235.77. The firm has a fifty day moving average of $201.87 and a 200-day moving average of $197.17. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts predict that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.81% of the stock is currently owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently added to or reduced their stakes in THC. NewEdge Advisors LLC lifted its holdings in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare during the 2nd quarter worth approximately $290,000. Chicago Partners Investment Group LLC bought a new position in shares of Tenet Healthcare during the second quarter worth approximately $273,000. Finally, Stephens Inc. AR bought a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $306,000. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.